Terry Kohler - 26 Feb 2026 Form 3 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
CFO and Treasurer
Signature
/s/ Terry Kohler, by Michael A. Goldstein as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
3
Filing time
26 Feb 2026, 21:00:15 UTC
Previous filing
21 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kohler Terry CFO and Treasurer C/O ADMA BIOLOGICS, INC., 5800 PARK OF COMMERCE BLVD. NW, BOCA RATON /s/ Terry Kohler, by Michael A. Goldstein as Attorney-in-fact 26 Feb 2026 0001872285

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADMA Common Stock 58,019 26 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADMA Stock Option (Right to Buy) 26 Feb 2026 Common Stock 91,166 $19.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 8, 2025 (the "Grant Date"), ADMA Biologics, Inc. granted the Reporting Person 58,019 restricted stock units ("RSUs"), which vest 25% on the one-year anniversary of the Grant Date and each annual anniversary of the Grant Date, over four years, subject to the Reporting Person's continued service as of the applicable vesting date, and which RSUs will be settled into common stock upon vesting.
F2 These stock options were granted to the Reporting Person on the Grant Date, and will vest over four years with 25% vesting on the Grant Date and the remaining 75% vesting monthly in equal installments over the next three years subject to the Reporting Person's continued service as of the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney